📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hematopoietic stem cell gene therapy targeting TGFß enhances the efficacy of irradiation therapy in a preclinical glioblastoma model. (2021)

First Author: Andreou T

Attributed to: Institute of Cancer Research - Equipment Account funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2020-001143

PubMed Identifier: 33707311

Publication URI: http://europepmc.org/abstract/MED/33707311

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal for immunotherapy of cancer

Issue: 3

ISSN: 2051-1426